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3. Abstract
The relationship between preoperative hypertension and intraoperative 
haemodynamic changes known to be associated with postoperative morbidity 
Hypertension is not consistently associated with postoperative cardiovascular morbidity and 
therefore not considered a major peri-operative risk factor. However, hypertension may 
predispose to peri-operative haemodynamic changes known to be associated with peri-
operative morbidity and mortality, such as intra-operative hypotension and tachycardia. The 
objective of this study was to determine whether pre-operative hypertension was 
independently associated with haemodynamic changes known to be associated with 
adverse peri-operative outcomes. We performed a five-day multicentre, prospective, 
observational cohort study which included all adult inpatients undergoing elective, non-
cardiac, non-obstetric surgery. We recruited 343 patients of whom 164 (47.8%) were 
hypertensive. An intra-operative mean arterial pressure of <55 mmHg occurred in 59 
(18.2%) patients, of which 25 (42.4%) were hypertensive. Intra-operative tachycardia (heart 
rate>100 beats per minute) occurred in 126 (38.9%) patients, of which 61 (48.4%) were 
hypertensive. Multivariable logistic regression did not show an independent association 
between the stage of hypertension and either clinically significant hypotension or 
tachycardia, when controlled for ASA physical status, functional status, major surgery, the 
duration of surgery or blood transfusion. There was no association between pre-operative 
hypertension and peri-operative haemodynamic changes known to be associated with major 
morbidity and mortality. These data therefore support the recommendation of the Joint 
Guidelines of the Association of Anaesthetists of Great Britain and Ireland (AAGBI) and the 
British Hypertension Society to proceed with elective surgery if a patient’s blood pressure is 
<180/110 mmHg.  
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7.b) Summary
Hypertension is not consistently associated with postoperative cardiovascular morbidity and 
therefore not considered a major peri-operative risk factor. However, hypertension may 
predispose to peri-operative haemodynamic changes known to be associated with peri-
operative morbidity and mortality, such as intra-operative hypotension and tachycardia. The 
objective of this study was to determine whether pre-operative hypertension was 
independently associated with haemodynamic changes known to be associated with 
adverse peri-operative outcomes. We performed a five-day multicentre, prospective, 
observational cohort study which included all adult inpatients undergoing elective, non-
cardiac, non-obstetric surgery. We recruited 343 patients of whom 164 (47.8%) were 
hypertensive. An intra-operative mean arterial pressure of <55 mmHg occurred in 59 
(18.2%) patients, of which 25 (42.4%) were hypertensive. Intra-operative tachycardia (heart 
rate>100 beats per minute) occurred in 126 (38.9%) patients, of which 61 (48.4%) were 
hypertensive. Multivariable logistic regression did not show an independent association 
between the stage of hypertension and either clinically significant hypotension or 
tachycardia, when controlled for ASA physical status, functional status, major surgery, the 
duration of surgery or blood transfusion. There was no association between pre-operative 
hypertension and peri-operative haemodynamic changes known to be associated with major 
morbidity and mortality. These data therefore support the recommendation of the Joint 
Guidelines of the Association of Anaesthetists of Great Britain and Ireland (AAGBI) and the 
British Hypertension Society to proceed with elective surgery if a patient’s blood pressure is 
<180/110 mmHg.  
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7.c) Introduction
Hypertension is a common global health problem with an estimated prevalence of 30%  [1] 
and is a preventable cause of premature morbidity and mortality  [2]. The current Joint 
Guidelines of the Association of Anaesthetists of Great Britain and Ireland (AAGBI) and the 
British Hypertension Society recommend proceeding with elective surgery if the blood 
pressure (BP) is  <180/110 mmHg  [3], although the evidence for this recommendation 
remains limited  [4, 5, 6]. 
Hypertension alone is not considered a major peri-operative risk factor, because it is not 
consistently associated with postoperative morbidity  [4, 6, 7, 8, 9]. However, the 
complications associated with hypertension are known to increase peri-operative risk, and 
these include coronary artery disease, congestive cardiac failure, renal failure, 
cerebrovascular disease and diabetes mellitus  [10, 11]. Patients with known cardiovascular 
disease or established risk factors for cardiovascular disease have a 6-7% risk of a major 
adverse cardiac event (MACE) within 30 days of surgery  [12, 13, 14]. 
Pre-operative hypertension may predispose to intra-operative haemodynamic instability 
known to be associated with adverse peri-operative outcomes  [3, 15, 16], although the 
current evidence supporting this is limited. Peri-operative haemodynamic responses that 
have been associated with major adverse outcomes in non-cardiac surgical patients include 
intra-operative hypotension  [17, 18]. Walsh et al. defined intra-operative hypotension as a 
mean arterial pressure (MAP) of < 55 mmHg. A MAP of <55 mmHg for more than one 
minute was independently associated with myocardial injury and acute kidney injury 
following surgery. A MAP of <55 mmHg for more than twenty minutes was independently 
associated with increased mortality  [18]. Tachycardia has also been associated with 
myocardial ischaemia and adverse cardiac events  [19, 20]. Beattie at al. showed that a 
heart rate (HR) > 100 beats per minute (bpm) was associated with an adverse outcome 
[21]. 
If pre-operative hypertension independently predisposes to haemodynamic changes known 
to be associated with adverse outcomes in the peri-operative period, then it is possible that 
this may be an important risk predictor. It is possible that poor pre-operative control of BP, or 
a higher hypertensive stage (Table 1) may be associated with an increased risk of 
haemodynamic instability in the peri-operative period  [16]. 
Previous peri-operative hypertension studies of haemodynamic instability have not 
adequately controlled for other known risk factors independently associated with MACE 
[16], which include the American Society of Anesthesiologists (ASA) physical status  [22], 
functional status  [23], major surgery  [8, 22], duration of surgery  [24] and blood transfusion 
[25]. We decided to determine whether pre-operative hypertension was independently 
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associated with peri-operative haemodynamic instability known to be associated with 
adverse peri-operative outcomes. 
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7.d) Methods
Study approval was obtained from the University of Cape Town Faculty of Health Sciences 
Human Research Ethics Committee, the Western Cape Department of Health, as well as 
institutional approval from all participating centres. All patients provided written informed 
consent and we followed the STROBE statement  [26]. This was a five-day, multicentre, 
prospective, observational cohort study at seven public sector, government funded, hospitals 
in the Western Cape of South Africa. Eligible participants included all adult inpatients 
undergoing elective, non-cardiac, non-obstetric surgery. Exclusion criteria were day case 
patients, cardiac, obstetric or emergency surgery, paediatric patients and patients having 
radiological or local ophthalmology procedures. 
Pre-operative and intra-operative data collection was performed by the attending 
anaesthetist on a paper case report form. The pre-operative data included: patient baseline 
characteristics (age, weight, height and sex); ASA physical status; functional status; type of 
surgery; anti-hypertensive therapy; any chronic diseases and pre-operative creatinine value 
(within 30 days of surgery). Functional status assessment was based on history in 
accordance with the Gupta et al Cardiovascular Risk Calculator and the ACS NSQIP risk 
calculator [28]. Pre-operative BP measurements and baseline HR were recorded on the day 
before surgery. The BP measurements were conducted in accordance with 
recommendations in the Joint Guidelines from the Association of Anaesthetists of Great 
Britain and Ireland (AAGBI) and the British Hypertension Society  [3]. Three BP 
measurements were taken and recorded the day before surgery for the accurate diagnosis 
of pre-existing or undiagnosed hypertension  [27]. In addition, we determined whether the 
pre-operative electrocardiogram (ECG), performed within six months of surgery, 
demonstrated left ventricular hypertrophy or an irregular rhythm. During the intra-operative 
period, the data recorded included pre-induction BP and HR, the duration of observed intra-
operative hypotension (MAP <55 mmHg) and tachycardia (HR >100 bpm), type of 
anaesthesia, minor, intermediate or major surgery  [28], the duration of surgery, intra-
operative fluid administration (type and volume) and intra-operative vasopressor 
requirements. Data recorded on the paper case report forms were captured electronically 
onto the Research Electronic Data Capture (REDCap) application by local investigators. 
Access to the data entry system was username and password protected. Patient 
confidentiality and anonymity was ensured through the generation of a unique numerical 
code during the electronic data transcription.  
The primary aim of the study was to determine whether the stage of pre-operative 
hypertension was independently associated with an intra-operative MAP of <55 mmHg for 
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more than one minute i.e whether preoperative hypertension is associated with 
intraoperative hypotension. The secondary aims were to determine whether the stage of pre-
operative hypertension was independently associated with a MAP <55 mmHg for >20 
minutes and/or a HR >100 bpm. In the multivariable model, a priori we planned to include 
the pre-operative hypertension stage and the following five peri-operative risk factors known 
to be independently associated with MACE: ASA physical status ≥3, functional status, 
duration of surgery, need for blood transfusion and major surgery. Based on the need for six 
risk predictors to be included in a multivariable model, we required approximately 60 primary 
outcome events, to ensure that we had 10 events per variable  [29]. Based on previous work 
in our surgical population, we estimated that we would require a sample size of 
approximately 500 participants, as we anticipated that approximately 150 (30%) patients 
[27] would be hypertensive and that 44% of these would experience intra-operative
hypotension [18]. Based on our expected elective surgical volume at the participating
hospitals, we believed that we could recruit this number of participants in five days.
For statistical analysis, the categorical independent binary variables in Table 2 were 
described as proportions and analysed using Fisher exact and Chi square testing. The 
continuous numerical data in Table 2 were described as mean (central tendency) and 
standard deviation (dispersion). A MAP < 55 mmHg and HR >100 bpm were risk adjusted for 
ASA physical status  [22], functional status  [23], duration of surgery  [24], blood transfusion 
[25] and major surgery  [8, 22]. An HR >100 bpm was also risk-adjusted for β-adrenergic
antagonist therapy. Multivariable logistic regression was performed for the primary and
secondary objectives, using Statistical Package for the Social Sciences (SPSS) version 21
(SPSS Inc., Chicago, IL, USA) software.
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7.e) Results
The study flow diagram is shown in Figure 1. Three hundred and twenty-four patients were 
included in the multivariable analysis. Table 2 shows the characteristics of the study 
population. Hypertension occurred in 164 (47.8%) of elective surgical participants of which 
133 (81.1%) were known to have hypertension and 31 (18.9%) had undiagnosed 
hypertension. Hypertensive patients were older, had a higher BMI and ASA physical status 
and were more likely to have diabetes mellitus, renal failure, retinopathy or partial functional 
dependence. Surgery was longer in hypertensive patients, with increased blood loss, when 
compared with normotensive patients. The distribution of hypertension stages in the study 
population is shown in Table 1. Of the known hypertensive patients, 83 (51%) were 
controlled and 50 (37.6%) were inadequately controlled on existing anti-hypertensive 
treatment. The anti-hypertensive medications included diuretics in 62.2%, angiotensin 
converting enzyme inhibitors in 48.2% and β adrenergic antagonists in 32.9%. The Revised 
Cardiac Risk Index(RCRI) scoring system was completed on the entire patient population 
presenting for elective surgery including healthy ASA 1 patients who do not routinely require 
creatinine measurement. The RCRI score incorporates an elevated creatinine as a risk 
factor and therefore 20 patients lack RCRI data. 
Table 1: Hypertensive participants classified according to stage of hypertension and 
described as number (proportions). Stages of hypertension as recommended by the Joint 
Guidelines from the Association of Anaesthetists of Great Britain and Ireland (AAGBI) and 
the British Hypertension Society  [3]. 
Hypertension stage Systolic BP 
(mmHg) 
Diastolic BP 
(mmHg) 
Study population 
Normotensive <140 <90 83 (51%) 
Hypertension stage 
1 
140-159 90-99 55 (34%) 
Hypertension stage 
2 
160-179 100-109 19 (12%) 
Hypertension stage 
3 
≥180 ≥110 7 (3%) 
BP: Blood pressure 
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Figure 1: Study flow diagram including participant recruitment rate 
MAP : mean arterial pressure, HR: heart rate, bpm: beats per minute 
Our expected elective surgical volume at the participating centers was 500 participants. The 
5 days our study was conducted only 397 patients presented for elective surgery. We did not 
feel we had to extend the data collection period as we had obtained enough primary 
outcome variables to include in the multivariable model. We anticipated that approximately 
150 (30%) patients would be hypertensive [27], but our study revealed a hypertension rate of 
48.7%  instead with a 20 % intraoperative hypertension rate. This resulted in a smaller 
sample size, but it did not affect the power of the study. 
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Table 2: Baseline characteristics of the study population. Values are mean (SD) or number 
(proportion). 
Baseline 
characteristics 
Study 
population 
Hypertensive 
population 
Normotensive 
population 
p value 
Age; years 49 (16) 57 (13) 41 (14) <0.01 
Sex; male 130 (38%) 58 (35%) 72 (40%) 0.37 
BMI 28 (7) 30 (7) 27 (7) <0.01 
ASA physical 
status 
1 121/340 
(36%) 
18/164 (11%) 103/176 (59%) <0.01 
2 159/340 
(47%) 
98/164 (60%) 61/176 (35%) 
3 54/340 (16%) 43/164 (26%) 11/176 (6%) 
4 6/340 (2%) 5/164 (3%) 1/176 (1%) 
Functional status 
Totally 
independent 
296/335 
(88%) 
133/159 (84%) 163/176 (93%) <0.01 
Partially 
dependent 
33/335 (10%) 26/159 (16%) 7/176 (4%) 
Totally dependent 6/335 (2%) 0/159 (0%) 6/176 (3%) 
Hypertension-associated target organ damage 
LVH on ECG 33/343 (10%) 29/164 (18%) 4/179 (2%) <0.01 
CRF and low 
eGFR 
22/247 (9%) 20/147 (14%) 2/100 (2%) <0.01 
Complications of hypertension 
CAD 11/343 (3%) 9/164 (6%) 2/179 (1%) 0.03 
Heart failure 5/343 (2%) 4/164 (2%) 1/179 (1%) 0.20 
Stroke 6/343 (2%) 5/164 (3%) 1/179 (1%) 0.11 
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PAD 8/343 (2%) 6/164 (4%) 2/179 (1%) 0.16 
Retinopathy 5/343 (2%) 5/164 (3%) 0/179 (0%) 0.02 
Concomitant risk factors for cardiovascular disease 
Smoking 148/343 
(43%) 
61/164 (37%) 87/179 (47%) 0.03 
Dyslipidaemia 41/343 (12%) 34/164 (21%) 7/179 (4%) <0.01 
IDDM 33/343 (10%) 27/164 (17%) 6/179 (3%) <0.01 
NIDDM 15/343 (4%) 10/164 (6%) 5/179 (3%) 0.19 
RCRI 
0 220/323(68%
) 
85/156 (55%) 135/167 (81%) 0.80 
1 88/323 (27%) 58/156 (37%) 30/167 (18%) 0.65 
2 12/323 (4%) 10/156 (6%) 2/167 (1%) 0.40 
3 3/323 (1%) 3/156 (2%) 0/167 (0%) 1.00 
Blood loss during 
surgery (ml) 
136 (212) 183 (274) 92 (116) <0.01 
Duration of 
surgery (minutes) 
97 (65) 108 (72) 86 (55) <0.01 
Major Surgery 46 (13%) 26 (16%) 20 (11%) 0.37 
BMI: body mass index, LVH: left ventricular hypertrophy, ECG: electrocardiogram, CRF: 
chronic renal failure, low eGFR: estimated glomerular filtration rate less than 60ml.min-
1.1.73m-2, CAD: coronary artery disease, PAD: peripheral arterial disease, IDDM: insulin 
dependent diabetes mellitus, NIDDM: non insulin dependent diabetes mellitus, RCRI: 
revised cardiac risk index 
Pre-induction BP>140/90 mmHg occurred in 81 (23.6%) of participants. All undiagnosed 
hypertensive patients had a pre-induction BP>140/90 mmHg and none of the normotensive 
participants had pre-induction hypertension. There was a significant increase in BP and HR 
prior to induction when compared with the ward recordings on the day prior to surgery 
(Figure 2).  
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Figure 2: Pre-operative ward measurements compared with pre-induction measurements of 
blood pressure and heart rate of patients included in the study. 
bpm: beats per minute, MAP: mean arterial pressure, SBP: systolic blood pressure, DBP: 
diastolic blood pressure, HR: heart rate, ◆ p<0,01,   p= 0,022 
The primary outcome, a MAP<55 mmHg for >1 minute intra-operatively, occurred in 59 
(18.2%) patients. Twenty-five (42.4%) were hypertensive, and this constituted 15,2% of the 
hypertensive cohort. A MAP<55 mmHg for >20 minutes intra-operatively, occurred in 4 
(1.2%) patients, of which none were known hypertensives. An intra-operative HR of >100 
bpm occurred in 126 (38.9%) patients, of which 61 (48.4%) were hypertensive. This 
constituted 39.1% of the hypertensive cohort. None of the patients with stage 3 hypertension 
developed clinically significant intra-operative hypotension, so we collapsed hypertensive 
stages 2 and 3 into a single variable for the purposes of logistic regression. After risk 
adjustment for a MAP <55 mmHg and a HR of >100 bpm with ASA physical status, 
functional status, major surgery, hypertensive stages, blood transfusion and duration of 
surgery (and  adrenergic antagonist therapy for HR), pre-existing hypertension was not 
independently associated with clinically important intra-operative hypotension or tachycardia. 
The univariable and multivariable associations with the primary and secondary outcomes are 
shown in Tables 3 and 4 respectively.  None of the predictors were independently 
associated with the primary or secondary outcomes.  
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Hypertensive participants received more intra-operative vasopressors (p=0.04) and total fluid 
therapy (p=0.04) when compared with normotensive patients. Blood was administered to 8 
(2.3%) patients. 
Table 3: Univariable and multivariable associations with a mean arterial pressure (MAP) 
<55mmHg. 
Univariable Multivariable 
OR 95% CI p 
value 
OR 95% CI p 
value 
Functionally dependent 1.7 0.8-3.9 0.16 2.5 0.9-6.9 0.07 
ASA physical status ≥ 3 0.9 0.4-1.8 0.68 0.5 0.2-1.3 0.15 
Major surgery 1.5 0.7-3.2 0.29 1.0 0.4-2.5 1.00 
Duration of surgery per 
minute 
1.005 1.001-1.009 0.02 1.004 1.0-1.008 0.11 
Blood transfusion 4.8 1.2-19.6 0.03 3.7 0.7-19.2 0.12 
Hypertension ≥ stage 2 0.9 0.3-2.7 0.84 0.9 0.3-2.8 0.83 
OR: odds ratio, CI: confidence interval 
Table 4: Univariable and multivariable associations with a heart rate >100 beats per minute.  
OR: odds ratio, CI: confidence interval 
Univariable Multivariable 
OR 95% CI p 
value 
OR 95% CI p 
value 
Functionally dependent 1.2 0.59-2.33 0.66 1.0 0.42-2.2 0.93 
ASA physical status ≥3 1.4 0.76-2.5 0.29 1.4 0.66-2.8 0.38 
Major surgery 2.3 1.2-4.4 0.01 2.0 0.95-4.1 0.07 
Duration of surgery per 
minute 
1.005 1.001-
1.009 
0.01 1.004 1.000-
1.008 
0.06 
Blood transfusion 2.7 0.63-11 0.18 0.96 0.19-4.8 0.95 
Hypertension ≥ stage 2 1.1 0.49-2.6 0.77 0.94 0.38-2.3 0.89 
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7.f) Discussion
Hypertension is common amongst elective surgical patients, with a prevalence of 47.8% in 
our patient population, which is higher than the estimated 30% worldwide prevalence. 
Hypertension was associated with higher ASA physical status, decreased functional status, 
older age and obesity, all of which increase the risk for cardiovascular disease and adverse 
peri-operative outcomes. However, our data failed to find an association between pre-
existing hypertension and clinically important haemodynamic instability in the peri-operative 
period.  
Intra-operative hypotension was common, with 18.2% of elective surgical patients 
developing a MAP <55 mmHg for at least a minute, and 1.2% for more than 20 minutes. 
However, our data failed to show a significant association between any of the known peri-
operative cardiovascular risk predictors and intra-operative hypotension.  In addition, pre-
operative hypertension was not independently associated with an intra-operative 
tachycardia. We did not investigate whether hypotension and tachycardia occurred 
simultaneously. There is however good evidence that shows that hypotension and 
tachycardia is associated with adverse outcomes individually [18, 21]. 
Our results suggest that pre-operative hypertension is not an independent predictor of 
haemodynamic instability and lend support to the recommendation of the Joint Guidelines 
from the Association of Anaesthetists of Great Britain and Ireland (AAGBI) and the British 
Hypertension Society as well as the South African recommendation by James et al [30], that 
if a patient’s BP is <180/110 mmHg it is safe to proceed with elective surgery.  
No patients with stage 3 hypertension developed clinically significant intra-operative 
hypotension, so we cannot provide data on the risk for haemodynamic instability in this sub-
group but we do advocate caution. A pre-induction systolic BP of ≥140 mmHg or diastolic 
BP≥90 mmHg should consider possible referral of the patient to an appropriate primary 
healthcare facility for further screening and management following surgery.  
One strength of this study is that it was adequately powered to determine the association 
between pre-existing hypertension and other known independent predictors of major 
adverse cardiac events, with clinically important intra-operative hypotension. We believe our 
findings provide some support to the recommendation to proceed with surgery when the pre-
operative BP is <180/110 mmHg. Furthermore, it did not find any compelling reasons not to 
follow the proposed guidelines.  
Our study has some limitations. Firstly, due to the limited number of events of MAP<55 
mmHg for >20minutes, and the limited number of participants with stage 3 hypertension, we 
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are unable to explore the relationship between pre-existing hypertension and prolonged 
intra-operative hypotension. Further work is necessary to address this area. Secondly, 
because our data collection was not electronically captured and the attending anaesthetists 
were required to document the duration of hypotension in minutes, we expect that there may 
well have been a Hawthorne effect as a result. Thirdly, although this study was conducted in 
a middle-income country, we believe that the findings are generalisable to high-income 
countries, but recommend external validation of these data. Intra-operative hypotension is 
common and is associated with major morbidity and mortality. However, the determinants of 
intra-operative hypotension remain unclear. Further work is necessary to determine 
independent risk predictors for clinically important intra-operative hypotension. Furthermore, 
it is important to establish whether treating intra-operative hypotension will improve 
postoperative outcomes. Finally, this study only addressed a surrogate outcome 
(intraoperative hypotension), and not hard outcomes, such as myocardial injury or death.  
In conclusion, hypertension is common amongst elective, non-cardiac, non-obstetric 
patients. Pre-existing hypertension up to stage 2 is not independently associated with intra-
operative hypotension or tachycardia known to be associated with adverse peri-operative 
outcomes. Therefore we believe that the Joint Guidelines from the Association of 
Anaesthetists of Great Britain and Ireland (AAGBI) and the British Hypertension Society as 
well as the South African recommendation as per James et al [30], which recommend 
proceeding with elective surgery if blood pressure is <180/110 mmHg, are appropriate. We 
would advise caution in patients with stage 3 hypertension, as our study contained 
insufficient numbers to determine whether there was an association between stage 3 
hypertension and clinically important intra-operative haemodynamic changes. It would 
appear that hypertension is a public health issues rather than a peri-operative problem  [9]. 
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Synopsis 
This is a proposal for a substudy of ‘An Audit of the Prevalence of Hypertensive Disease in 
Patients Presenting for Elective Surgery’ by Dr Karen van der Spuy. 
Hypertension is a major public health problem in the Western Cape, and is the 15th leading 
cause of years of life lost in Southern Sub-Saharan Africa [1], and between 40 and 50% of 
patients in middle-income countries have hypertension [2]. The anaesthetist is therefore 
often responsible for administering anaesthesia to hypertensive surgical patients.  
Pre-operative hypertension has been associated with physiological derangements such as 
intra-operative hypotension, hypertension and arrhythmia, but the association between these 
haemodynamic fluctuations and significant postoperative clinical morbidity is unclear [3, 4]. 
Furthermore, it is unclear whether pre-operative in hospital blood pressure measurements 
are the correct measurements to use as an indicators of  peri-operative risk [5]. Therefore, 
the effects of elevated pre-operative blood pressure measurements and its impact on 
perioperative and long term morbidity remain unclear in elective surgical patients [3].  
The hypothesis of this substudy is that pre-operative hypertension may be associated with 
peri-operative morbidity.  This substudy will therefore evaluate the relationship between the 
pre-operative in hospital blood pressure and intra-operative haemodynamic changes which 
are known to be associated with postoperative morbidity.  
This is a prospective observational study of adult, non-cardiac, non-obstetric elective surgery 
patients conducted over a period of one week.  
The primary objective is to categorize patients into the following groups based on their pre-
operative in hospital blood pressure measurement: 
• SBP<140mmHg and DBP <90mmHg
• SBP<160mmHg and DBP<100mmHg
• SBP<180mmHg and DBP<110mmHg without end organ damage
• SBP<180mmHg and DBP<110mmHg with end organ damage
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These patients will be risk adjusted for duration of surgery, the need for intra-operative blood 
transfusion, pre-operative anaemia, ASA status, functional status, major surgery as well as 
type of anaesthesia. 
Pre-operative in hospital blood pressure as described above and its association with intra-
operative hypotension i.e. MAP < 55mmHg for >1minute as defined by Walsh et al [6] will be 
evaluated.  
The secondary objectives are to determine the relationship between preoperative in hospital 
blood pressure measurement and MAP<55mmHg for >20min [6], HR>100 beats per minute 
[7], volume and type of fluid administered as well as the use of perioperative vasopressors. 
If a relationship can be demonstrated between pre-operative hypertension and significant 
hypotension, it will allow for identification of patients at risk of perioperative morbidity who 
could be identified pre-operatively during routine clinical examination and blood pressure 
measurement. This will allow the anaesthetist to better anticipate these haemodynamic 
changes and intervene appropriately to prevent adverse outcomes. It will also encourage 
further research with regards to management of the pre-operative elevated blood pressure 
and hopefully the development of a standard approach or evidence based guideline with the 
ultimate goal to improve the peri-operative management and outcomes in this patient group. 
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Abbreviations and Acronyms 
SBP: Systolic Blood Pressure 
DBP: Diastolic Blood Pressure 
BP: Blood Pressure 
MAP: Mean Arterial Pressure 
HR: Heart Rate 
GSH: Groote Schuur Hospital 
NICE: National Institute for Health and Care Excellence 
AAGBI: Association of Anaesthetists of Great Britain and Ireland 
UCT: University of Cape Town 
IOH: Intra-operative Hypotension 
LVH: Left Ventricular Hypertrophy 
AKI: Acute Kidney Injury 
MINS: Myocardial Injury after Non-cardiac Surgery 
MI: Myocardial infarction 
SPSS: Statistical Package for Social Sciences 
mmHg: Millimetres of Mercury 
ASA: American Society of Anesthesiologist; Physical classification system 
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Background and Rationale for substudy 
Introduction: 
Hypertension is an important disease of our time and has been described by NICE as ‘one of 
the most important preventable causes of premature morbidity and mortality in the United 
Kingdom’[8] [3]. Hypertension is a major public health problem in the Western Cape, and is 
the 15th leading cause of years of life lost in Southern Sub-Saharan Africa [1], and between 
40 and 50% of patients in middle-income countries have hypertension[2].  
The anaesthetist is therefore often responsible for administering anaesthesia to hypertensive 
surgical patients. Elective surgery is often postponed due to elevated pre-operative blood 
pressure, although the evidence for this is currently lacking [9]. Hypertension is a major 
burden to both the patient and public health system resources. The lack of evidence and 
guidelines with regards to postponement of surgery due to elevated blood pressure leads to 
variable anaesthetic practises that cause confusion amongst patients, surgeons and referral 
centres [10].  It is therefore imperative to establish the relationship between pre-operative 
hypertension and peri-operative outcomes. To this end, it is important that an emphasis 
should be placed on directing management and interventions based on the cardiovascular 
risk associated with hypertension rather than simply targeting a numerical blood pressure 
value peri-operatively. 
Peri-operative hypertension: 
Hypertension will be defined as per main study[11]: 
[12]
36 
37 
Patients may present with peri-operative hypertension due to several factors, including [3]: 
• Pre-operative
o False hypertension measurements (e.g. white coat)
o Undiagnosed hypertension
o Poorly controlled hypertension in known chronic hypertensive patients
• Intra-operative and postoperative
o Induction of anaesthesia
o Airway manipulation
o Acute pain
o Hypothermia
o Hypoxia
o Consequences of fluid therapy
Although, hypertension is an established risk factor for cardiovascular disease [5] with good 
evidence-based guidelines for the diagnosis and management of adult hypertension in the 
community, there remains poor guidance on ‘safe’ blood pressures for elective surgery [3]. It 
is for this reason that the AAGBI (Association of Anaesthetists of Great Britain and Ireland) 
and the British Hypertension Society have made the following recommendations in their joint 
guidelines with regards to elective surgery patients: 
• Primary care objectives
o Diagnosing and obtaining control of blood pressures below 160 mmHg systolic
and 100 mmHg diastolic over a period of 12 months before referral for elective
surgery [3]
• Secondary care objectives
o Avoid false hypertensive measurements [3].
o Do not attempt to diagnose hypertension in patients who are normotensive in
primary care [3]. This has been criticized due to the occurrence of mask
hypertension that is associated with high cardiovascular risk and consequently
diagnostic opportunities should not be missed [10].
• Patients with no documented primary care blood pressures
o Proceed with elective surgery if blood pressures are below 180 mmHg systolic
and 110 mmHg diastolic[3].
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In stage 1 or 2 hypertension (SBP <180mmHg and DBP < 110mmHg) in the absence of 
target organ damage there is currently no clear evidence of increased peri-operative 
cardiovascular risk and surgery should not be postponed [3] [12]. However, in known 
hypertensive patients with resultant target organ damage, there is an increased incidence of 
peri-operative major adverse cardiovascular events [3, 13].  It remains unclear however, 
whether postponing elective surgery for adequate blood pressure control in these patients 
decreases the rate or occurrence of adverse cardiovascular events [1, 6][12]. The risk 
benefit of delaying surgery to establish hypertension control should always be considered in 
patients with severe hypertension[12] 
Target organ damage as described in the South African hypertension guidelines practice 
guidelines 2014 includes[14]: 
• Left Ventricular Hypertrophy (LVH) on ECG
o Sokolow-Lyons > 35 mm
o R in aVL > 11 mm
o Cornel > 2 440 (mm/ms)
• Microalbuminuria
o Spot Albumin: Creatinin ratio 3–30 mg/mmol
o eGFR > 60 ml/min
Hypertensive patients are known to have a labile intra-operative haemodynamic course 
fluctuating between hypertension and hypotension [3].  Hypotension occurs as a result of 
decreased systemic vascular resistance which is exaggerated during deep anaesthesia and 
in fluid-depleted patients. Hypertensive patients also tend to have exaggerated 
haemodynamic responses to surgery, pain and emergence [3, 15]. It is possible that these 
haemodynamic responses may be associated with postoperative morbidity. 
Intra-operative hypotension: 
Hypertensive patients often have a labile intra-operative haemodynamic course as described 
above. Hypotension during anaesthesia often requires intervention in the form of 
vasopressors or fluid administration. We suspect that hypertensive patients receive 
increased volumes of fluid within this context. 
39 
Fluid management remains a controversial topic in the literature with on-going debate 
concerning type and volume of fluid. Current recommendations with regards to volume of 
fluid administered suggest avoiding fluid overload and opting for a zero fluid balance 
approach to fluid therapy which entails the replacement of losses and maintaining normal 
bodyweight.  It is accepted that a liberal fluid strategy with subsequent fluid overload is 
associated with post-operative complications as a consequence of tissue inflammation and 
oedema. Avoidance of fluid overload therefore improves outcome.[16, 17]  
Short cumulative durations (i.e. < 30 min) of intra-operative hypotension (IOH) during 
vascular surgery are not associated with myocardial injury [18]. In eldely vascular surgery 
patients there is however a higher incidence of postoperative myocardial infarction and 
death within 30 days in patients with mean arterial pressure (MAP) less than 60 mmHg and 
in patients with a 40% decrease from pre-induction MAP with a cumulative duration of more 
than 30 min there is an association with postoperative myocardial injury [18]. However, MAP 
of less than 55mmHg of even a short duration has been associated with increased risk of 
acute kidney injury (AKI) and myocardial injury postoperatively due to an ischemia–
reperfusion injury that leads to organ dysfunction [6]. 
Intra-operative hypotension remains poorly defined. This substudy will define IOH as per 
Walsh et al and will take into account the cumulative and not continuous duration of IOH [6]. 
Peri-operative tachycardia 
A heart rate of <100 beats per minute has been proven to be associated with 
cardioprotection whereas heart rates of >100 beats per minute has not demonstrated any 
cardioprotection [7]. Effective  heart rate control has been established to reduce the 
incidence of postoperative myocardial infarction (MI) and is therefore an important factor in 
achieving cardioprotection peri-operatively[7].  
In general an increase in baseline heart rate is linked with increased cardiovascular risk and 
mortality. Pertaining non-cardiac surgery an association between pre-operative heart rate of 
>96 beats per minute and post-operative Myocardial Injury after Non-cardiac Surgery
(MINS), MI and mortality has been established by Abbott et al[19].
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In conclusion 
The current literature suggests that pre-operative hypertension is associated with 
haemodynamic fluctuations, although their clinical significance is unclear [3, 4]. Furthermore, 
the clinical risk associated with pre-operative in hospital blood pressure measurements are 
also unclear [5]. Finally, most perioperative studies that have attempted to illustrate 
associations between different numerical blood pressure thresholds and peri-operative 
outcomes are underpowered [5].  
We believe that we could address these limitations in the literature, by evaluating the 
relationship between pre-operative blood pressure measurements and intra-operative 
haemodynamics which have been specifically associated with post-operative morbidity. 
The null hypothesis of this substudy is that in-hospital pre-operative hypertension is not 
associated with intra-operative haemodynamics known to be associated with postoperative 
morbidity. The alternate hypothesis is that in-hospital pre-operative hypertension is 
associated with intra-operative haemodynamics known to be associated with postoperative 
morbidity. Should this be the case, then those patients at risk could be easily identified pre-
operatively through blood pressure measurement, and this would allow the anaesthetist to 
better anticipate these haemodynamic changes and intervene appropriately to prevent 
adverse peri-operative outcomes. It will also encourage further research with regards to 
management of the pre-operative elevated blood pressure and hopefully the development of 
a standard approach or evidence based guideline to improve the peri-operative management 
and outcomes of this patient group. 
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Study Aims and Objectives 
Study aim 
The aim of this sub study is to determine the relationship between pre-operative blood 
pressure measurements and intra-operative haemodynamic changes that have been 
demonstrated in the literature to be associated with peri-operative morbidity 
Objectives 
Primary objective 
The primary objective is to categorize patients into the following groups based on their pre-
operative in hospital blood pressure measurement: 
• SBP<140mmHg and DBP <90mmHg
• SBP<160mmHg and DBP<100mmHg
• SBP<180mmHg and DBP<110mmHg without end organ damage
• SBP<180mmHg and DBP<110mmHg with end organ damage
These patients will be risk adjusted for: 
• Duration of surgery
• Need for blood transfusion intra-operatively
• Pre-operative anaemia
• ASA status
• Functional status
• Major surgery
• Type of anaesthesia (Dependant on sample size)
Pre-operative in hospital blood pressure as described above and its association with intra-
operative hypotension i.e. MAP < 55mmHg for >1minute as defined by Walsh et al [6] will be
evaluated.
Secondary objectives: 
The secondary objectives are to determine the relationship between preoperative in hospital 
blood pressure measurement and the following:  
i. MAP<55mmHg for >20min [6]
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ii. HR>100 beats per minute [7]
iii. Volume and type of fluid administered
iv. Use of perioperative vasopressors
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Methodology 
Study design 
This is a substudy of Dr Karen van der Spuy’s study titled; An Audit of the Prevalence of 
Hypertensive Disease in Patients Presenting for Elective Surgery’. This will be a prospective 
observational study of adult, non-cardiac, non-obstetric elective surgical patients conducted 
over a period of one week. 
Study population 
The study population comprises all adult non-cardiac, non-obstetric patients presenting for 
elective surgery at Groote Schuur Hospital, Somerset Hospital, Paarl Hospital, Victoria 
Hospital, Mitchell’s Plain Hospital, Worcester Hospital and George Hospital over a period of 
one week.  
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The study population sample size is estimated at 500 patients. We anticipate that 150 of 
these patients will be hypertensive (30% of patients [2]). If 44% of these patients are affected 
by intra-operative hypotension [6], this would approximate to 66 patients. This number will 
allow us to attest approximately 6 to 7 variables as described in the study aims and 
objectives, 
Inclusion criteria: 
• Adult patients presenting for non-cardiac, non-obstetric, elective surgery
Exclusion criteria: 
• Paediatrics
• Cardiac patients
• Obstetric patients
• Emergency surgery
Setting 
Elective surgical patients at Groote Schuur Hospital, Somerset Hospital, Paarl Hospital, 
Victoria Hospital, Mitchell’s Plain Hospital, Worcester Hospital and George Hospital over a 
period of one week. 
Study methods 
The study will identify patients with pre-operative in hospital blood pressure measurements 
as follows: 
• SBP<140mmHg and DBP <90mmHg
• SBP<160mmHg and DBP<100mmHg
• SBP<180mmHg and DBP<110mmHg without end organ damage
• SBP<180mmHg and DBP<110mmHg with end organ damage
The following data will be collected for all elective surgical patients: 
• Intra-operative hypotension:
o MAP<55mmHg <1min
o MAP<55mmHg >20min
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• HR > 100 beats per minute
• Volume and type of fluid administered
• Pre-operative anaemia
• ASA status
• Functional status
• Type of anaesthesia
o General anaesthesia
o Epidural
o Spinal
• Type of surgery – major or not
• Duration of surgery
• Were vasopressors required as well as specific vasopressors used
• Blood pressure cuff size
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Ethical considerations 
This study is in effect a large scale clinical audit. We therefore expect that there will be no 
requirement for individual patient consent as all data will be anonymised and is already 
recorded as part of routine clinical care. All data will be recorded by anaesthetic registrars 
and consultants on a separate case report form designed for the purpose of this study during 
the patients theatre visit. Patient identifying data will not be captured on the case report form 
and thereby data will be kept confidential.  
The study will record pre-operative blood pressure measurements, pre-operative anaemia, 
intra-operative hypotension (MAP<55mmHg) and duration thereof, HR > 100 beats per 
minute,  volume and type of fluid administered intra-operatively, ASA status, functional 
status, type of anaesthesia, type of surgery , duration of surgery, intra-operative 
vasopressors requirements as well as specific vasopressors used as well as blood pressure 
cuff size.  
The aforementioned are all documented routinely during a patient’s anaesthetic and will not 
influence patient management or theatre practice but would rather reflect current clinical 
practice.  
The study is purely observational and therefore no interventions will take place and no 
adverse events as a result of participation in this substudy are anticipated. Standard theatre 
safety precautions and clinical practice apply. It will be a once off anonymous data collection 
and no patient follow up will be required. 
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Study administration 
Logistics, time schedule and action plan 
The logistics, time schedule and action plan, will be as per the main study; ‘Prior to 
commencement of the study, the researcher will communicate the intention, purpose and 
execution of the study with fellow registrars and colleagues, and recruit and encourage their 
participation in data collection verbally, by electronic mail as well as instant messaging. 
Posters will be placed in the anaesthetic department as well as in all the theatres in which 
the elective lists take place to serve as reminders. 
Prior to each surgical elective day for the period of the study, the surgical lists for all the 
disciplines will be collected from the theatre matron and collated with the weekly 
anaesthesiology theatre allocation roster. Each anaesthesiology registrar/consultant will 
receive a data collection sheet for each patient on the elective list for the following day, as 
well as a brief summary of the information to be documented on the data capture sheet. 
All information to be recorded on the data capture sheet is routinely captured prior to 
anaesthetic or surgical intervention. Demographic, medical and surgical information is 
generally routinely available following patient assessment. Furthermore, these blood 
pressure measurements are routinely performed and documented. These details will be 
recorded on the data collection form so patient files, records or notes will not be altered or 
removed for study purposes. 
Finally, no additional measurements, tests or investigations will be performed which might 
place the patient at risk, or discomfort, or impose any additional cost or other burden on 
patient or institutional resources. 
On arrival at the theatre complex, each patients’ folder or anaesthetic chart will be checked 
for the presence of the study data capture form, as well as for any errors in the completion 
thereof. 
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Data for each patient will be recorded on a separate, specifically designed data collection 
form, completed by the anaesthesiology registrar and/or consultant providing the anaesthetic 
for the patients prior to and during the surgical time period. This will serve as a further 
reminder regarding the information to the captured as well as ensure that no patient records 
are removed or altered from the patients’ hospital folder. 
The forms will be collected by the researcher or research assistants in the recovery room of 
the main theatre, or as each patient exits the theatre complex.  
The forms collected will be collated with the hospital record of all patients having entered the 
theatre complex each day, so as to determine the degree of uptake of data. 
The study will take place over a period of one week and involve all elective non-cardiac, non-
obstetric surgical cases scheduled from a Monday morning at 07h00 to a Friday evening at 
07h00.’[11] 
Resources and Cost 
The resources and cost, are as per the main study; ‘Elective patient preoperative, 
intraoperative assessment and blood pressure measurement is a routine procedure 
undertaken by all anaesthesiology registrars/consultants prior to and during surgical 
intervention. The predominant use of resources will thus involve time taken to complete the 
data capture form from information already available and recorded in patient’s clinical notes 
and anaesthesiology records. 
Printing of the data capture forms, posters and other stationary required will be provided for 
by the researcher. 
The researcher will require time out of theatre during the chosen week of the study to ensure 
data capture forms are distributed, completed in full, and then collected. 
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The collation of data capture forms, correlation with theatre records, as well data capture will 
be effected by the researcher, during research allocated time. 
Departmental appointed statisticians will provide assistance with statistical analysis as 
required. Research monies will be motivated for, to ensure this cost is covered.’[11] 
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Data management and analysis 
All data will be captured on the case report forms and entered into excel and then SPSS for 
data analysis. 
Collection of data will depend on fellow anaesthetic registrars and consultants under the 
supervision of the research team. The research team will include the authors of the primary 
study and substudy as well as supervisors, co-supervisors and statisticians.  Data will be 
handled by the research team as described. Data will be kept anonymous as no patient 
identifying details will be recorded on the case report forms. Completed case report forms 
will be kept in the GSH Anaesthetic department (D23). 
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Reporting of results 
Study results will be recorded and submitted in the form of a MMed dissertation to the 
University of Cape Town for assessment as per postgraduate requirements. These results 
will also be made available to the public. 
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Attachments 
1. Case report form
2. Elective theatre list schedule
3. Anaesthetic record
4. Karen Van der Spuy’s research proposal
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8.c) Case report form
HASS unique patient ID 

Patient name: ___________________________________       DOB 
Patient hospital number : _________________________ 
m m d d y y y y 
Hypertension and Surgery Study (HASS) Consent given  F  Yes    F  No 
Age  years Gender  F  M    F  F   Current smoker F Y F  N 
Ethnicity: F Black    F Coloured    F Asian  F Caucasian 
Height                     cm            Weight   kg ASA  F  I    F  II    F  III    F  IV    F  V  
Blood results (no more than 30 days before surgery): Haemoglobin   .  g/dL  Creatinine  µmol/L 
Chronic co-morbid disease (tick all that apply): 
F  Coronary artery disease      F  Heart failure     F  Advanced retinopathy 
F  Stroke or Transient ischaemic attack F  COPD / Asthma F  HIV / AIDS  
F  Known hypertension F  Chronic renal disease F  Peripheral arterial disease 
F  Diabetes (without insulin) F  Diabetes (requiring insulin) F  High cholesterol or statin Rx 
Functional status:  F  Totally independent   F  Partially dependent    F  Totally dependent 
Pre-operative ECG (within the last 6 months) (tick all that apply): 
F  LVH (left ventricular hypertrophy)    F  Rhythm irregular     F  ECG not done  
Surgical procedure category (select single most appropriate): 
F  Anorectal F  Aortic F  Bariatric 
F  Brain F  Breast F  ENT (except thyroid/parathryroid) 
F  Foregut (hepatopancreaticobiliary) F  Gallbladder, appendix, adrenal, spleen F Hernia (ventral, inguinal, femoral) 
F  Intestinal F  Neck (thyroid/parathyroid) F  Gynaecology 
F  Orthopaedic/ nonvascular extremity F  Other abdominal F  Peripheral vascular 
F  Skin F  Spine F  Non-oesophageal thoracic 
F  Vein F  Urology 
Current antihypertensive medications i.e. taking for at least 30 days prior to hospital admission (tick all that apply): 
F  ACE-I or ARB F  Diuretic F  Beta-blocker 
F  Calcium channel blocker F  Alpha-blocker F  Other 
Drug compliance (tick all that apply): Do you ever forget to take your medication? F Y F  N 
Are you careless at times about taking your medication? F Y F  N  
When you feel better, do you sometimes stop taking your medication? F Y F  N 
Sometimes if you feel worse when you take the medicine, do you stop taking it? F Y F  N 
Reasons for non-drug compliance (only answer if 2 or more drug compliance questions above marked ‘Yes’): 
Health system F Condition F Patient F  Therapy F  Socioeconomic F 
Blood pressure during pre-operative assessment: BP measured with:  F  automated     F  manual 
1st BP reading:    SBP DBP MAP HR 
2nd BP reading (if 1st >140/90):  SBP DBP MAP 
3rd BP reading (if 1st >140/90): SBP DBP MAP 
HASS unique patient ID 

Patient name: ___________________________________       DOB 
Patient hospital number : _________________________ 
m m d d y y y y 
Surgery performed:     F  Yes F  No If no, reason: _____________________________________ 
Pre-induction blood pressure: SBP DBP MAP HR 
Anaesthetic technique (D)    F General   F Spinal      F Epidural       F Sedation     F Local F Other regional 
Major surgery: F Y F  N  
Blood loss during surgery:     ml Duration of surgery:  minutes 
Vasopressors:     F  Phenylephrine F  Ephedrine  F  Adrenaline 
Intraoperative fluid administration: 
Total volume given (ml) 
Crystalloid 
Colloid 
Blood 
Intraoperative haemodynamics (please record total intra-operative time in minutes): 
Heart rate > 100:  F  No   F  Yes       If yes, total time HR> 100       minutes  
MAP < 55mmHg F  No   F  Yes       If yes, total time MAP<55mmHg          minutes 
Perioperative data capture 
HASS unique patient ID 

Patient name: ___________________________________       DOB 
Patient hospital number : _________________________ 
m m d d y y y y 
Guidance for use of paper case record form (CRF) 
Remove this page before use in data collection 
1. Baseline data on page one should be collected on the preoperative anaesthetic visit on the day before
surgery.
2. BP assessment during the preoperative anaesthetic visit should ideally be measured as follows;
Allow patient to sit for 3–5 minutes before commencing measurement. The SBP should be first estimated by
palpation to avoid missing the auscultatory gap. If the 2nd and 3rd readings 1–2 minutes apart, are only
required if the 1st reading >140/90. If there is a discrepancy in readings between arms, then use the side with
the higher BP.  The patient should be seated, back supported, arm bared and arm supported at heart level.
Patients should not have smoked, ingested caffeine-containing beverages or food in previous 30 min. An
appropriate size cuff should be used: a standard cuff (12 cm) for a normal arm and a larger cuff (15 cm) for an
arm with a mid-upper circumference > 33 cm (the bladder within the cuff should encircle 80% of the arm).
Measure BP after 1 and 3 minutes of standing at first consultation in the elderly, diabetics and in patients
where orthostatic hypotension is common. When adopting the auscultatory measurement use Korotkoff 1 and
V (disappearance) to identify SBP and DBP respectively. Take repeated measurements in patients with atrial
fibrillation and other arthythmias to improve accuracy.1
3. Baseline data on page two should be collected on the anaesthetist who provides the anaesthesia for
the patient.
4. Definitions:
a. Advanced retinopathy: defined as haemorrhages or exudates or papilloedema
b. LVH ECG definitions; defined as;
i. S in V1 plus R in V5 or V6 > 35 mm or
ii. R in aVL > 11 mm or
iii. (R in aVL + S in V3 + 6 in females) × QRS duration > 2 440 (mm/ms)
c. Major surgery: defined as Aortic and other major vascular surgery, peripheral vascular surgery, or
intraperitoneal or intrathoracic surgery with major fluid shifts
d. Non-drug compliance definitions;2
HASS unique patient ID 

Patient name: ___________________________________       DOB 
Patient hospital number : _________________________ 
m m d d y y y y 
i. Health system: Poor quality of provider-patient relationship; poor communication; lack of
access to healthcare; lack of continuity of care
ii. Condition: Asymptomatic chronic disease (lack of physical cues); mental health disorders (eg,
depression)
iii. Patient: Physical impairments (eg, vision problems or impaired dexterity); cognitive
impairment; psychological/behavioural; younger age;
iv. Therapy: Complexity of regimen; side effects
v. Socioeconomic: Low literacy; higher medication costs; poor social support
5. Please try to ensure complete data submission. If an ECG or blood results are not available at the time of the
preoperative anaesthetic assessment, please can the anaesthetist for the operative procedure complete these
data.
Reference 
1. Hypertension guideline working g, Seedat YK, Rayner BL, et al. South African hypertension practice
guideline 2014. Cardiovasc J Afr 2014;25(6):288-94. doi: 10.5830/CVJA-2014-062 
2. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes.
Circulation 2009;119(23):3028-35. doi: 10.1161/CIRCULATIONAHA.108.768986 
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8.d) Informed consent document
INFORMED CONSENT FORM 
Title of Studies: 
An audit of the prevalence of hypertensive disease in patients presenting for elective 
surgery. HREC ref: 661/2016 
Is there a relationship between pre-operative blood pressure measurement and intra-
operative haemodynamic changes that are known to be associated with postoperative 
morbidity? HREC ref: 708/2016 
Investigators: Dr Karen van der Spuy, Dr Marcelle Crowther, Dr Marcin Nejthardt, Dr Francois 
Roodt, Prof Bruce Biccard 
Department of Anaesthesia and Perioperative Medicine, University of Cape Town, South 
Africa 
INFORMATION 
You are being approached to be a part of a research study on blood pressure. The doctors 
that are part of this study are trying to understand more about your blood pressure before 
and during surgery.  
If you have no objection, the doctors would appreciate your permission to collect information 
relating to your blood pressure measured in the ward, in theatre and during your surgery. 
This study will have no benefits for you, but may help doctors treat patients in the future. 
If you agree to be a part of this study, the doctors will be collect the following information, 
which is routinely written down as part of your standard patient care in hospital: 
• Your blood pressure, factors known to be associated with high blood pressure and blood
pressure medication, and
• Details about your operation which include how long the operation took, the type of
intravenous fluids, any changes in your blood pressure and heart rate, and whether any
medication was given to manage your blood pressure.
Being a part of this study will not result in any additional measurements, tests or 
investigations during your time in the hospital. The only difference for patients in the study 
when compared to standard care patients, is that the above information will be taken down 
by one of the doctors. This information will be stored both on paper and on computer. To 
protect your privacy, the information will be labelled in a way that will not identify you. If the 
results of these studies are published, your identity will be kept confidential.  
By signing this form, you are allowing the use of this information for the research study. These 
research projects have been approved by the University of Cape Town’s Human Research 
Ethics Committee. If you have any ethical concerns or questions about your rights or welfare 
as a participant in this research, the Human Research Ethics Committee can be contacted on 
021 406 6338.  
Please read this form carefully and ask the investigator (study doctor) to explain any words or 
information that are not clear to you. This will help to ensure you understand the details of 
your participation before you give your consent. You will be given a copy of this consent form 
to take home with you. The doctors will answer any questions you may have about this 
consent form and about the studies. 
CONSENT STATEMENT 
I therefore certify the following: 
• I have read the above information form and understand that the study involves
research.  
• I understand that the doctors will make a copy of some of my routinely recorded data
from my standard patient care.
• I have had the opportunity to ask questions.  All my questions have been answered to
my satisfaction.
• I understand that any information that leaves the doctor’s office will be de-identified
(i.e., identifying information will be removed from the documents).
______YES __________ NO 
Participant/Legal Representative’s name (printed) Signature Date: 
Name of person obtaining consent (printed) Signature Date: 
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8.e) Anaesthesia author guidelines
Anaesthesia author guidelines 
PREPARATION OF MATERIAL 
Layout 
A typical manuscript will have the following sections in the following order: 
Title page 
The name and full postal address of the corresponding author should appear in the top left-hand corner. The rest of the page 
should follow this example: 
Title of paper that does not state the conclusion or pose a question* 
A. B. Author,1 C. D. Author2 and E. F. Author3 
1 Position/designation of 1st author, primary institution, city, country. 
2 Position/designation of 2nd author, primary institution, city, country. 
3 Position/designation of 3rd author, primary institution, city, country. 
Correspondence to: Dr Corresponding Author (incl. e-mail address) 
*footnote if presented in part at any national or international meetings, with details including location and date.
Short title of up to 60 characters suitable for a running header 
N.B. Place the superscript number after the commas in the list of authors. Please do not include authors’ qualifications. 
Please note that statements such as 'Author XX and Author YY both contributed equally to this work' are not used. 
Keywords 
Each manuscript should have 3 to 5 keywords identified on the title page. Please only use keywords from this list here. 
The title should describe the purpose and contents of the paper as well as possible; in general, this should not exceed 20 
words. Include relevant key-words e.g. randomised controlled trial, prospective, observational, etc. 
Summary 
The Summary should follow the sequence of the main body of the text, i.e. introduction, methods, results, discussion, but 
should not be structured. It should briefly state the purpose of the study or investigation; basic procedures; important results 
(giving numbers studied, values for results with p values) including relevant findings from Results, Tables and Figures; and 
principal conclusions. 
Use the same sequence when presenting the methods and results as in the main body of the text, always mention the groups 
in the same order, and ensure that the numbers in the Summary exactly match those in the main body; it may be preferable to 
write the summary after having finished writing the main paper, in order to ensure that these features match. 
The Summary should only exceed 250 words in exceptional circumstances. Abbreviations should not be used except for 
units of measurement. 
Introduction 
The Introduction should give a concise account of the subject’s background. Previously published work should only be 
quoted if it has a direct bearing on the present study. The Introduction should clearly and explicitly state the aims of the 
project. 
Methods 
A statement confirming Local Research Ethics Committee approval and written informed consent should be at the beginning 
of this section (see Ethical Considerations, below). 
The Methods section must describe in sufficient detail the techniques and processes used so that the investigation can be 
interpreted and repeated by readers. Any modification of previously published methods should be described and the 
appropriate reference given. If the methods are commonly used, only a reference to the original source is required. If special 
equipment is used, then the manufacturer’s details (including town and country) should be given in parentheses. Drugs 
should be identified by their recommended international non-proprietary names (NB adrenaline and noradrenaline are used 
in preference to epinephrine and norepinephrine). Label groups in a way that is easy to follow; thus ‘propofol group’ and 
‘thiopental group’ instead of ‘Group P’ and ‘Group T’. (Occasionally, abbreviated group titles may be better, e.g. ‘Group 
BLAB’ instead of ‘bupivacaine-lidocaine-adrenaline-bicarbonate group’). Remember to include inclusion/exclusion criteria 
and a justification of sample size. For randomised controlled trials, sufficient detail should be given on the following to 
allow readers to properly judge the risk of bias in the study: random sequence generation, allocation concealment, blinding 
(of patients, investigators, clinical staff, observers/assessors as appropriate) and handling of dropouts/withdrawals (intention 
to treat principle). Selective reporting bias will be assessed by comparison of the report with its protocol/trial registry entry 
(see above). The statistical methods used to investigate data should be given at the end of the Methods section (see below). 
Results 
Express results as mean (SD), median (IQR [range]) or number (proportion) as appropriate. Results (including actual p 
values) must be presented for all measurements detailed in the Methods section, and in the same order. Results should not be 
repeated unnecessarily. For example, if a graph is used, do not also present the same information in the text or in a Table. 
Results should not be given to an unwarranted number of decimal places and 95% confidence intervals should be used where 
possible (see Statistics, below). 
In randomised trials, baseline data (age, ASA physical status, duration of operation, etc.) should not be subjected to 
statistical comparison, since it is already known that the subjects were randomly allocated and that any difference is 
therefore due to chance. Describe characteristics and, if possible, allow for differences in the analysis and discussion. 
When reporting the effect of an intervention, absolute risk (AR), relative risk (RR) and ‘number needed to treat’ (NNT) are 
more easily understood by readers and may be preferable to odds ratio (OR). 
Graphs and tables should be appropriate for the data to be displayed. Tables usually convey more precise numerical 
information; graphs should be reserved for highlighting changes over time or between treatments. 
Avoid judgemental terms such as ‘very’ or ‘highly’ significant. 
Report actual p values, rather than ranges or limits (e.g. p=0.032, rather than p<0.05). 
Suggestions: 
• Use ‘survival’ curves for outcomes that are time e.g. ‘time to extubation‘ or ‘time to hospital discharge’, particularly if
it is the primary outcome
• Means should be expressed to a sufficient precision that they are different, with a minimum of three significant digits
e.g. 372, 37.2, 3.72, 0.372 etc.
• Means should be followed by the standard deviation, not the standard error.
• Standard deviations do not need to be different and should be a minimum of two significant digits.
• Rates should be followed by proportion if the denominator exceeds 100, e.g. 90/200 (45%) but 9/20.
Discussion
The Discussion should not merely recapitulate the results but should present their interpretation against a background of
existing knowledge. Any conclusions must be warranted by the results. In general, avoid a paragraph headed ‘Conclusions’ 
that merely repeats a summary of the results. Also avoid ending with ‘further work is needed’ (it almost always is) unless 
you have specific areas of research to suggest. 
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Appendices 
Information or data not directly a result of the study but necessary for the reader to understand the manuscript should be 
included as an Appendix. Examples might include copies of questionnaires used, recognised mathematical processes used to 
generate results or previously published and validated classification systems. All should be appropriately referenced and the 
authors must obtain permission from the copyright holders if the contents have been previously published. 
References 
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the first time in Tables or Figures should be numbered in the sequence established by the first mention of the particular 
Table/Figure in the text. All references (including those in press) should be listed at the end of the text in the order they are 
quoted. For internet sites, please include the date accessed in parentheses. List all authors unless there are seven or more, in 
which case give the first three followed by ‘, et al.’ The journal title should be written out in full and in italics, followed by a 
semi-colon then a space followed by the edition number in bold (no sub-edition numbers please) then a colon then a space 
and finally the page numbers. 
Examples: 
1. Author AB, Author CD. Title of paper. Journal Title Written Out in Full in Italics 2010; 12: 123-4.
2. Author AB, Author CD. Title of paper published as 'ePub ahead of print'. Journal Title Written Out in Full in
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3. Author AB, Author CD, Author EF, et al. Seven or more authors – what’s the point? (chapter title). In: Editor GH,
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The International Committee of Medical Journal Editors has stated that: "Authors are responsible for checking that none of
the references cite retracted articles except in the context of referring to the retraction. For articles published in journals
indexed in MEDLINE, the ICMJE considers PubMed the authoritative source for information about retractions. "Retracted 
articles can be identified by using the following search strategy in PubMed, e.g. for an author J. Smith enter "Smith*J AND 
retracted publication[pt]". 
Tables 
Include the Tables in the same file as the text, but after the References not in the middle of the text. Each Table should be on 
a separate page. Number the Tables consecutively with Arabic numerals. Each Table should have a brief Caption 
immediately above it; the Caption should provide enough information for readers to follow it without having to look through 
the text (e.g. ‘Characteristics of patients receiving vecuronium or rocuronium for caesarean section’ rather than just 
‘Patients’ characteristics’). The Caption should explain whether the values refer to mean (SD), number (proportion), etc. 
Abbreviations should not be mentioned in the Caption without explanation. Abbreviations used in the body of the Table 
should be explained as footnotes in the order in which they are first mentioned. 
For adults: age, weight, height and BMI should be expressed as mean (SD). 
For children: age, weight, height and BMI should be expressed as median (IQR [range]). 
The study groups should form the columns rather than the rows. If statistical comparisons are being made, a separate column 
with exact p values should appear. 
Example: 
Figures 
Please supply each Figure as a separate file, rather than embed them within the body of the Word document or in the 
covering email, and preferably in TIFF or high-resolution JPEG format. We ask that they are both supplied at a resolution of 
300 pixels per inch for photographs and 600 pixels per inch for line art or a combination of photograph and labelling. Please 
do not send image files larger than 10MB. 
Please ensure related graphs have the same format (fonts, use of symbols, etc.), and that the groups are presented in the same 
order in each graph (and in the same order as in the rest of the manuscript). The same requirements for abbreviations and 
units apply as for those in the text. The title, plot frame, gridlines and legend box within the graph itself should be removed, 
with symbols and error bars explained in the Caption. Avoid the use of 3-D unless absolutely necessary. Please note that 
colour Figures (e.g. photographs, complex flow diagrams, etc.) may be used without charge. 
Captions for Figures 
Each Figure Caption should include an explanation of the symbols used to provide enough information for readers to follow 
it without having to look through the text. 
Thus this: 
Figure 1 Itching after surgery in patients receiving saline (  ) or chlorphenamine (  ). No significant difference between 
groups. 
Is preferable to this: 
Figure 1 Itching after surgery. 
See notes below for ethical considerations relating to photographs. 
Supporting Information (online only) 
Additional material such as video clips, lengthy Appendices (e.g. extensive reference lists or mathematical 
formulae/calculations), etc. that are relevant to a particular article but not suitable or essential for the print edition of the 
Journal, may also be considered for publication. Please refer to all supporting information in the manuscript using Table S1, 
Figure S1, etc. and supply such information as separate files (i.e. not embedded within the main manuscript). Further 
information on suitable file formats, etc. may be found here. 
Language 
Please note that Anaesthesia uses UK English spelling e.g. “ise” not “ize”, “anaes” not “anes”, etc. In general, we prefer a 
clear, precise style to jargon. Please avoid long, complicated sentences and the passive voice when the active is more 
appropriate (e.g. ‘We chose epidural anaesthesia because...’ instead of ‘Epidural anaesthesia was chosen by the authors 
because...’). Remove unnecessary clutter and focus on the actual message of each sentence; thus ‘Hypotension is important 
because...’ instead of ‘It would be remiss of us not to mention hypotension because...’). Remember that lungs are ventilated, 
not patients (nor are they intubated – their tracheas are). 
Similarly, patients are not induced – anaesthesia is – or put on ventilators. Correct terms are tracheal (not endotracheal) tube 
and neuromuscular blocking drugs (not muscle relaxants). Please refer to recent issues of the Journal for preferred 
wording/spelling, e.g. “manikin” is preferred to “mannequin”, and “supraglottic airway device” is preferred to “extraglottic 
airway device”. 
The abbreviation LMA is only to be used if referring to a specific device made by The Laryngeal Mask Company Ltd, and 
with the first mention in the Summary and in the main text highlighted by (R) and ‘LMA is a registered trade mark of The 
Laryngeal Mask Company Ltd, an affiliate of Teleflex Incorporated’ as a footnote. If used, the correct format is ‘LMAâ 
laryngeal mask’ for the first mention (n.b. not just ‘LMAâ’) and ‘LMA laryngeal mask’ thereafter. The same to apply to 
LMAâ Classic, LMAâ Flexible, LMAâ Fastrach (n.b. previously labelled ILMAâ), LMAâ ProSeal, LMAâ Supreme, LMAâ 
Unique (n.b. ‘cLMA’ not to be used). The generic term of ‘laryngeal mask’ should be used for describing inflatable-cuff 
supraglottic airways in general. 
Abbreviations 
In general, the Journal does not encourage the use of abbreviations, especially in the Summary, since their frequent use 
makes papers cluttered and difficult to read. However, we will accept abbreviations in the following circumstances: 
• Universal abbreviations that do not need to be written out in full when first mentioned in the text. These include
abbreviations that appear in a large proportion of the articles published in the Journal, e.g. ASA, BMI, ECG, ICU,
HDU, SD, SEM, 95% CI, IQR, ANOVA, SpO2, FIO 2, pH.
• Acceptable common abbreviations that can be used but should be written out in full at their first mention, e.g. CNS,
CSF, HME, PEEP, PCA, SCBU, CTG, EEG, BIS, CVP, PAP, PCWP, ECT – unless they’re only mentioned a few
times, in which case please spell them out throughout. Please do not use abbreviations that are clumsy or will be
unfamiliar to the majority of readers, e.g. DI (difficult intubation), TTFB (time to first breath), etc.
• Acceptable abbreviations that do not need to be written out in full when first mentioned but whose use should be
restricted to situations where space is limited, such as in formulae or in Tables and Figures, e.g. O2, CO2, N2O, HCO3-,
Na+, K+, Mg2+.
Numbers and units 
Numbers should be spelled out in full when they start a sentence, and when they are less than 10 (unless they are followed 
by units of measurement). Thus: ‘Thirteen days later, five patients each received 7 ml solution...’ Commas are used to 
indicate thousands above 10,000: thus, 2000 and 20,000. Please give costs in sterling (£) with equivalent Euros and US 
dollars (€/$) in brackets. 
Use the format mg.kg-1 not mg/kg for all units. Use SI units throughout the text except for vascular pressure measurements 
(mmHg or cmH 2O) and haemoglobin concentration (g.l-1). Litres are indicated by lower case ‘l’ not upper ‘L’. Use the 24-
hour clock for times. 
Ethical considerations 
Whatever their other merits, manuscripts will only be considered for publication in Anaesthesia if they adhere to the highest 
ethical standards. These are detailed in two editorials published in the journal, that are available here and here and which 
potential authors are strongly advised to consult. 
The Editorial Board takes all cases of possible publication misconduct seriously and will investigate these according to the 
recommendations of the Committee on Publication Ethics (COPE). Further guidance can be found in our Editorial Policies. 
All clinical trials that prospectively assign human subjects to intervention or comparison groups to study the cause-and-
effect relationship between a medical intervention and a health outcome should be registered before the time of first 
recruitment. There are several public registries now available which meet the requirements of the ICMJE and these are listed 
on the WHO International Clinical Trials Registry Platform (ICTRP). The registry, registration number and date of 
registration must be stated in the Acknowledgements section of the manuscript. This should have been done before patient 
recruitment commenced. Reports of original research that were not registered before the study was carried out should 
include separate submission of the original protocol for the study. If the submitted report differs from the protocol, an 
explanation of the reason for this should be provided. Authors should be willing and able to submit their raw study data to 
the journal, if requested, after submission. 
Anaesthesia supports and encourages the use of the EQUATOR (Enhancing the QUAlity and Transparency Of health 
Research) Network guidelines to ensure the transparent and accurate reporting of research studies. The authors of clinical 
intervention studies are advised to review the CONSORT statement regarding the reporting of randomised trials prior to 
manuscript submission. 
We strongly encourage authors to register systematic review protocols on a similar database (for instance, 
PROSPERO http://www.crd.york.ac.uk/PROSPERO/). 
All clinical trails should be conducted in accordance with the ethical principles as set out in the Declaration of Helsinki. In 
brief, the minimum ethical standards for Anaesthesia include: 
• Approval by a Research Ethics Committee (REC) or equivalent Institutional Review Board (IRB) must be obtained
prospectively for all studies on human subjects, including studies in which participants’ skills are tested using
manikins. Some studies involving audit and epidemiological surveys, assessments of medical equipment or analysis of
previously collected, non-identifiable information from a database may be exempt from this stricture if participants are
appropriately protected against coercion and there is due regard to confidentiality. Publication of the results, however,
would usually still require informed consent and assurances regarding confidentiality (including approval by 
the Caldicott Guardian or equivalent for patient data and the relevant Research and Development department), even if
the REC/IRB has indicated that formal submission is unnecessary.
• While an essential preliminary step, REC/IRB approval does not guarantee that the ethical standards of a study will 
meet the requirements of the Editorial Board of Anaesthesia. If authors have any concerns that ethical issues might
compromise publication, they are invited to contact the Editor-in-Chief before embarking on the study.
• The Editorial Board supports the view of the ICH Harmonised Tripartite Guideline for Good Clinical Practice that full 
prospective written informed consent should be obtained from all subjects of clinical trials, including participants in 
manikin studies (see above). This would normally comprise provision of written information to potential research
participants, allowance of adequate time for them to consider their involvement and ask questions, and the use of
specific consent forms (for the study, not just for routine surgery/anaesthesia) that should be signed by the participants
to indicate their consent and then stored in case they require examination later.
• Submission of a case report requires the written consent of the subject to publication, using a specific form. Please do
not submit this document together with your manuscript but note that authors may be asked to provide the signed form 
as evidence, should a complaint result in a subsequent investigation. While the Editorial Board recognises that it might
not always be possible to seek such consent (or the assent of the next-of-kin if the patient has died), the onus will be on 
the authors to demonstrate that this exception applies in their case. Please state in an Acknowledgement at the end of
the text: ‘Published with the written consent of the patient(s)’ or similar, as appropriate.
• Studies of novel treatments, in particular drug studies where the agent used is given via unlicensed routes (especially 
neuraxial or perineural), may have received approval from the REC/IRB, but the Editorial Board is likely to reject such
studies if it considers that the risks posed outweigh the potential benefits. Such a conclusion is more likely to be
reached if the drug in question is not widely used in routine practice (as evidenced by inclusion in standard textbooks),
if the study participants are especially vulnerable (e.g. children, women in labour), if there are questions over consent,
or if only modest improvements in outcome are expected where other, well established methods already exist.
• Animal studies will only be considered for publication if they have ethical and governmental approval, and have been 
conducted under appropriate standards of care. Researchers will be expected to follow the ARRIVE guidelines for
experimentation in animal research.
Statistics 
It is difficult to provide generic guidance on statistics, since statistics are designed to test a hypothesis in a quantitative way 
and hypotheses differ across studies. Nevertheless, the following guidelines may help authors present their work in a better 
and more rigorous way that avoids common statistical errors that frequently lead to rejection. This should not be regarded as 
an exhaustive list and, of course, the Editorial Board and reviewers of manuscripts may ask authors for revisions that are not 
detailed here. However, adherence to these guidelines in a paper that is otherwise acceptable will provide authors with a 
good footing. 
Methods 
Randomisation methods should be made explicit (e.g. coin toss, random numbers, etc.). Please describe if stratification of the 
allocation system in a randomised controlled trial is performed (e.g. by age or recruiting centre) or block (permuted sequence 
or otherwise). For instance, most anaesthetic RCTs have exactly the same number of patients in each group but don't 
mention any blocking method (which would include putting equal numbers of folded pieces of paper for each group in an 
urn). Blinding must be as good as possible within constraints of clinical practice. 
Where there are several outcomes to be reported, the most important (primary) outcome should be clearly stated, along with 
any secondary outcomes. Beware of reporting as ‘significant’ or ‘important’ a positive result of a secondary outcome, when 
the study was in fact powered (sample sized) to a different primary outcome. 
Power analysis 
Some justification of sample size is always necessary for all observational studies, randomised or non-randomised controlled 
trials, or other types of study. Justification may be quantitative or qualitative (e.g. a ‘convenience sample’), although the 
latter may be regarded as weaker than the former. Details provided (for continuous variables) should include the power level; 
the significance level at which a result is sought; and the expected control and study group proportions or mean and pooled 
SD, in order to allow reviewers and readers to follow the calculation. The method used to justify power should be referenced 
and enough detail provided, so that the calculation can be repeated by readers. Conventionally, the power of study should be 
at least 80% but where different should be stated and justified. The ‘clinically important difference’ that the study is 
designed to detect should indeed be clinically relevant. Beware of setting an unreasonably large ‘clinically important 
difference’ to justify small sample size, as reviewers will recognise this is done simply to facilitate a small study. 
General rules: 
• Use mean (SD) unless data are discrete (e.g. Apgar scores, sedation scores) or grossly non-normally distributed: use
median (IQR [range]) or you are interested in the ‘true’ value for the population (use SEM).
• Visual analogue scores (VAS) for pain may be treated as continuous data and be subjected to parametric tests as long
as the sample size is large (> 50) and the data appear normally distributed. VAS for other modalities (nausea,
drowsiness) have not been so extensively validated and are best treated as ordinal data.
• Scales of measurement can be problematic (e.g. Cormack-Lehane scale, VAS, etc.) because a value of say 2 on the
scale does not imply something twice the value of 1, etc. So they cannot logically be regarded as linear, continuous
scales. It is safer to regard them as ordinal scales. However, for some scales such as VAS for pain it appears
established norm that this may be regarded as continuous, especially for large sample sizes (e.g. >50).
Inferential statistics 
• Use simple statistical tests where possible.
• Avoid multiple comparisons, or correct for them if used.
• Reference unusual tests; and assume that the more unusual the test used, the more likely will a specialist statistical 
referee review the paper.
• Include details of any computer package/version used.
• When looking for relationship between variables, use correlation to describe a simple descriptive association between 
two variables.
• Use regression to describe a quantitative relationship between two or more variables, especially where one is
predictive and other(s) dependent. Non-linear regression may be appropriate. Regression methods yield a formula to
relate the variables being described.
• Use the Bland-Altman method to describe the performance of two different methods used in measurement, analysis or
diagnosis.
Conclusions  
All conclusions should be warranted by the results and not extend beyond the confines of the study conditions. A negative 
result does not mean that there is definitely no difference (confidence in the conclusion is dependent upon the power of the 
study), and a positive result does not mean that there definitely is a difference (confidence in the conclusion is dependent 
upon the alpha error). 
The journal has a very useful statistic section containing articles which authors will find useful in preparing their 
manuscripts for statistical content: 
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2044/homepage/-statistics.htm 
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